These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24235084)

  • 1. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.
    Zumbrennen-Bullough K; Babitt JL
    Nephrol Dial Transplant; 2014 Feb; 29(2):263-73. PubMed ID: 24235084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
    Panwar B; Gutiérrez OM
    Semin Nephrol; 2016 Jul; 36(4):252-61. PubMed ID: 27475656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
    Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic iron homeostasis and erythropoiesis.
    Papanikolaou G; Pantopoulos K
    IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misdistribution of iron and oxidative stress in chronic kidney disease.
    Nakanishi T; Kuragano T; Nanami M; Nagasawa Y; Hasuike Y
    Free Radic Biol Med; 2019 Mar; 133():248-253. PubMed ID: 29958932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis-independent effects of iron in chronic kidney disease.
    Patino E; Akchurin O
    Pediatr Nephrol; 2022 Apr; 37(4):777-788. PubMed ID: 34244852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron-refractory iron deficiency anemia].
    Kawabata H
    Rinsho Ketsueki; 2016 Feb; 57(2):104-9. PubMed ID: 26935626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency.
    Suzuki T; Hanawa H; Jiao S; Ohno Y; Hayashi Y; Yoshida K; Kashimura T; Obata H; Minamino T
    J Card Fail; 2014 Apr; 20(4):268-77. PubMed ID: 24440572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Bahrainwala J; Berns JS
    Semin Nephrol; 2016 Mar; 36(2):94-8. PubMed ID: 27236129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron homeostasis and the inflammatory response.
    Wessling-Resnick M
    Annu Rev Nutr; 2010 Aug; 30():105-22. PubMed ID: 20420524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin is a potential regulator of iron status in chronic kidney disease.
    Tsuchiya K; Nitta K
    Ther Apher Dial; 2013 Feb; 17(1):1-8. PubMed ID: 23379486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.
    Akchurin O; Sureshbabu A; Doty SB; Zhu YS; Patino E; Cunningham-Rundles S; Choi ME; Boskey A; Rivella S
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F877-F889. PubMed ID: 27440777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron Homeostasis in Health and Disease.
    Gozzelino R; Arosio P
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.